Teza Capital Management’s Abiomed Inc ABMD Stock Holding History

Teza Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,083	Closed	-$266K	–	753
2022 Q3	$266K	Buy	+1,083	New	+$292K	0.06%	447
2020 Q3	–	Sell	-1,118	Closed	-$270K	–	661
2020 Q2	$270K	Buy	+1,118	New	+$224K	0.06%	410
2020 Q1	–	Sell	-2,521	Closed	-$430K	–	552
2019 Q4	$430K	Buy	+2,521	New	+$467K	0.12%	317
2019 Q2	–	Sell	-2,448	Closed	-$699K	–	492
2019 Q1	$699K	Buy	2,448 +779	+47%	+$259K	0.37%	98
2018 Q4	$542K	Buy	+1,669	New	+$580K	0.21%	171
2018 Q3	–	Sell	-4,010	Closed	-$1.64M	–	588
2018 Q2	$1.64M	Buy	+4,010	New	+$1.45M	0.24%	131

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Teza Capital Management's ABMD Position: Q4 2022 in Review

Teza Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,083 shares — an estimated $266K sold.

Teza Capital Management first reported a position in ABMD in Q2 2018 and held it in 6 quarters. The position peaked at $1.64M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Teza Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Teza Capital Management sold 1,083 Abiomed Inc shares in Q4 2022, an estimated $266K.
Teza Capital Management first reported a position in Abiomed Inc in Q2 2018 and held it in 6 quarters.
Teza Capital Management's Abiomed Inc position peaked at $1.64M in Q2 2018.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Teza Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.